Varda Shalev - 05 Jun 2025 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Director
Issuer ticker: TEVA
Reported as of: 05 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2025, 16:20:39 UTC
Prior SEC filing: 04 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Dov Bergwerk as attorney-in-fact for Varda Shalev

Key filing fact

Varda Shalev filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 09 Jun 2025.

Key facts

This page summarizes Varda Shalev's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Jun 2025, 16:20.

Change

Previous filing in this sequence was filed on 04 Sep 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001873934 Primary reporting owner

Shalev Varda

Relationship: Director
Address: C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL
Signature: /s/ Dov Bergwerk as attorney-in-fact for Varda Shalev
Signature date: 09 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +9,632
Change %: +75%
Price
Shares after: 22,504
Date: 06 Jun 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -9,632
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 06 Jun 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 9,632
Exercise price
Footnotes: F1, F2, F3

TEVA transaction Derivative

Restricted Share Units

Award

Transaction value: $0
Shares: +14,492
Change %
Price: $0.000000
Shares after: 14,492
Date: 05 Jun 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 14,492
Exercise price
Footnotes: F1, F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

Footnote F3

Restricted share units were granted on June 6, 2024 and vested on June 6, 2025.

Footnote F4

Restricted share units were granted on June 5, 2025 and vest on June 5, 2026.